Exane Derivatives’s McCormick & Company Non-Voting MKC Stock Holding History

Exane Derivatives’s Portfolio MKC Stock Details MKC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$666	Hold	8	–	–	﹤0.01%	545
2022 Q1	$798	Hold	8	–	–	﹤0.01%	823
2021 Q4	$773	Hold	8	–	–	﹤0.01%	733
2021 Q3	$648	Sell	8 -3,629	-100%	-$312K	﹤0.01%	910
2021 Q2	$312K	Buy	3,637 +3,615	+16,432%	+$322K	0.07%	278
2021 Q1	$1.96K	Hold	22	–	–	﹤0.01%	679
2020 Q4	$2.1K	Hold	22	–	–	﹤0.01%	622
2020 Q3	$2.13K	Hold	22	–	–	﹤0.01%	558
2020 Q2	$1.97K	Hold	22	–	–	﹤0.01%	503
2020 Q1	$1.55K	Hold	22	–	–	﹤0.01%	516
2019 Q4	$1.84K	Hold	22	–	–	﹤0.01%	500
2019 Q3	$1.72K	Hold	22	–	–	﹤0.01%	505
2019 Q2	$1.7K	Hold	22	–	–	﹤0.01%	519
2019 Q1	$1.66K	Hold	22	–	–	﹤0.01%	464
2018 Q4	$1.53K	Buy	22 +4	+22%	+$287	﹤0.01%	542
2018 Q3	$1.19K	Buy	+18	New	+$1.11K	﹤0.01%	526

Other funds holding MKC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FIS

Fundsmith Investment Services Grande Riviere Noire, Mauritius $4.52B AUM 8.53% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's MKC Position: Q2 2022 in Review

Exane Derivatives held its McCormick & Company Non-Voting (MKC) position steady in Q2 2022 at 8 shares worth $666. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Exane Derivatives first reported a position in MKC in Q3 2018 and has held it in 16 quarters since. The position peaked at $312K in Q2 2021. 956 funds tracked by Wall St. Rank hold MKC as of Q2 2022.

Exane Derivatives held 8 shares of McCormick & Company Non-Voting worth $666 as of Q2 2022.
Exane Derivatives left its McCormick & Company Non-Voting share count unchanged in Q2 2022.
McCormick & Company Non-Voting made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #545 holding.
Exane Derivatives first reported a position in McCormick & Company Non-Voting in Q3 2018 and has held it in 16 quarters since.
Exane Derivatives's McCormick & Company Non-Voting position peaked at $312K in Q2 2021.
956 funds tracked by Wall St. Rank held McCormick & Company Non-Voting as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.